tm
Seeing Is Believing
tm
Seeing Is Believing
NHI is currently covered by 4 analysts with an average price target of $96.8. This is a potential upside of $12.54 (14.88%) from yesterday's end of day stock price of $84.26.
National Health Investors's activity chart (see below) currently has 85 price targets and 59 ratings on display. The stock rating distribution of NHI is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 75.86% with an average time for these price targets to be met of 980.44 days.
Highest price target for NHI is $90, Lowest price target is $83, average price target is $85.25.
Most recent stock forecast was given by OMOTAYO OKUSANYA from CREDIT SUISSE on 20-Jan-2026. First documented stock forecast 11-Mar-2016.
Currently out of the existing stock ratings of NHI, 6 are a BUY (75%), 2 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Jan-2024
$85
$2.88 (3.51%)
$90
17 days ago
(20-Jan-2026)
7/11 (63.64%)
$4.83 (6.02%)
205
Buy Since 15-Aug-2025
$83
$0.88 (1.07%)
$81
1 months 21 days ago
(16-Dec-2025)
16/17 (94.12%)
$6.23 (8.12%)
486
Buy Since 26-Feb-2024
$90
$7.88 (9.60%)
$88
4 months 5 days ago
(01-Oct-2025)
4/6 (66.67%)
$10.18 (12.75%)
213
Buy Since 03-Mar-2025
$83
$0.88 (1.07%)
$62
11 months 3 days ago
(03-Mar-2025)
5/6 (83.33%)
$12.3 (17.40%)
1153
Hold
$63
$4.67 (8.01%)
1 years 11 months 11 days ago
(26-Feb-2024)
0/2 (0%)
$4.85 (8.34%)
What is NHI (National Health Investors) average time for price targets to be met?
Which analyst has the current highest performing score on NHI (National Health Investors) with a proven track record?
Which analyst has the current lower performing score on NHI (National Health Investors) with a proven track record?
Which analyst has the most public recommendations on NHI (National Health Investors)?
Which analyst is the currently most bullish on NHI (National Health Investors)?
Which analyst is the currently most reserved on NHI (National Health Investors)?
